Cargando...
Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
BACKGROUND: Rebamipide with mucin secretagogue activity was recently approved for the treatment of dry eye. The efficacy and safety in the treatment of rebamipide were shown in two pivotal clinical trials. It was the aim of this study to evaluate the effect of 2 % rebamipide ophthalmic suspension in...
Guardado en:
| Publicado en: | BMC Ophthalmol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4456696/ https://ncbi.nlm.nih.gov/pubmed/26048396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0040-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|